Clearside Biomedical, Inc.
CLSD
Revenue
90.00k
▼-140.00k▼-60.87%
3 Months ChangeAssets
33.93M
▼-6.21M▼-15.47%
3 Months ChangeLiabilities
62.22M
▲267.00k▲0.4310%
3 Months ChangeFree Cash Flow
-7.91M
▼-577.00k▼-7.87%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-10-09
Form 8-K
ID: 0000950170-24-113631
2024-08-12
Form 10-Q
ID: 0000950170-24-095489
2024-08-12
Form 8-K
ID: 0000950170-24-095451
2024-07-24
Form 8-K
ID: 0000950170-24-085864
2024-06-20
Form 8-K
ID: 0000950170-24-075603
2024-05-10
Form 10-Q
ID: 0000950170-24-057834
2024-05-09
Form 8-K
ID: 0000950170-24-056958
2024-04-16
Form 8-K
ID: 0000950170-24-044594
2024-03-12
Form 8-K
ID: 0000950170-24-029956
2024-02-08
Form 8-K
ID: 0001193125-24-028487